✦ LIBER ✦

Current status of DILD in molecular targeted therapies

✍ Scribed by Saito, Yoshinobu; Gemma, Akihiko

Book ID: 118792318
Publisher: Springer
Year: 2012
Tongue: English
Weight: 231 KB
Volume: 17
Category: Article
ISSN: 1341-9625
DOI: 10.1007/s10147-012-0494-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug-induced interstitial lung disease (

Drug-induced interstitial lung disease (DILD) in molecular targeted therapy

✍ Gemma, Akihiko 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 74 KB

Current status of targeted therapies in

Current status of targeted therapies in advanced gastric cancer

✍ De Vita, Ferdinando; Giuliani, Francesco; Silvestris, Nicola; Rossetti, Sabrina; 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 206 KB

Molecular targeted therapies in hepatoce

Molecular targeted therapies in hepatocellular carcinoma

✍ Josep M. Llovet; Jordi Bruix 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with several genomic alterations. There is evidence of aberrant activation of several signaling cascades such as epidermal growth factor receptor (EGFR), Ras/extracellular signal-regulated kinase, phosphoinositol 3-kinase/mammalian

Molecular targeted therapy for advanced

Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives

✍ Ying-Chun Shen; Chiun Hsu; Ann-Lii Cheng 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 293 KB

Current Status of Targeted Therapy in Me

Current Status of Targeted Therapy in Metastatic Renal Cell Carcinoma

✍ Pieter H.M. De Mulder; Jean-Jaques Patard; Cezary Szczylik; Thomas Otto; Tim Eis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 267 KB

Current status of bone-targeted therapy

Current status of bone-targeted therapy for cancer patients

✍ Alison T. Stopeck 📂 Article 📅 2011 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 64 KB